Search Results 91-100 of 17382 for Mmol

1. Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis - Mayo Clinic

   Dyslipidemia: Triglycerides ≥ 1.7 mmol/L (150 mg/dL); Dyslipidemia: High-density lipoprotein (HDL)-cholesterol < 40 mg/dL (male), < 50 mg/dL (female); Blood ...

2. TJ-68 Clinical Trial in Patients with Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps

   - Screening sodium level greater than 145 mmol/L, suggesting hypernatremia - Unstable or active medical or neurological (other than ALS) diseases which ...

3. Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET - Mayo Clinic

   Potassium level of up to 6.0 millimoles per liter (mmol/L) is acceptable at study entry if associated with creatinine clearance within normal limits ...

4. Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects With Elevated Risk - Mayo Clinic

   Fasting LDL-C ≥ 70 mg/dL (≥ 1.8 mmol/L) ) or non-HDL-C ≥ 100 mg/dL (> 2.6 mmol/L); Fasting triglycerides ≤ 400 mg/dL (4.5 mmol/L). Exclusion Criteria ...

5. A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM) (KarMMa-4) - Mayo Clinic

   Participation eligibility · Absolute neutrophil count < 1,000/μL; · Platelet count < 50,000 mm^3; · Hemoglobin < 8 g/dL (< 4.9 mmol/L); · Serum creatinine clearance ...

6. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

   a glucose value <60 mg/dL or ≤ 3.3 mmol/L at 90,120, 150 or 180 min during an OGTT. Patients must have at least one glucose level < 60 mg/dL (or ≤ 3.3 mmol ...

7. A Study of the Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity with Enteric LB1148 - Mayo Clinic

   Have a serum lactate level > 12.0 mmol/L at any point during the screening period; Serum lactate levels have improved (decreased) by greater than 50% at all ...

8. The BROADEN Study: A Study of Volanesorsen (Formerly ISIS-APOCIIIRx) in Patients With Familial Partial Lipodystrophy - Mayo Clinic

   Hypertriglyceridemia with Fasting TG levels ≥ 500 mg/dL (≥ 5.7 mmol/L) at Screening and Qualification visit, or Fasting TG levels ≥ 200 (≥ 2.26 mmol ...

9. Low-grade UTUC Treated with Nadofaragene Firadenovec Administered to Renal Pelvis - Mayo Clinic

   ... mmol/L * potassium between 3.6 and 5.0 mmol/L 11. Have an estimated glomerular filtration rate (eGFR) ≥45 mL/min/1.73 m2 (for inclusion in the safety lead ...

10. Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol - Mayo Clinic

    Serum LDL-C ≥1.8 millimole (mmol)/liter (L) (≥70 mg/dL). Fasting triglyceride <4.52 mmol/L (<400 mg/dL) at screening. Participants on statins should be ...